IKT: Inhibikase Therapeutics Uzoq muddatli qarzning kapitalga nisbati
Ushbu grafik GURU.Markets platformasida 0.00 vaqtida Inhibikase Therapeutics (IKT) kompaniyasining joriy bozor qiymatini aks ettiradi. Emitent opsion sxemalari va FDA mutaxassislarini jalb qilish orqali yetakchi neyrobiologlar jamoasini saqlab qolmoqda. Parkinson kasalligi dori vositalari ishlab chiqarishda avtomatlashtirilgan tizimlardan foydalaniladi, biroq yakuniy nazorat shifokorlar qo'lida qoladi. Biznes iqtisodiy sikllardan mustaqil bo'lgan barqaror talabga tayanadi, shunga qaramay, u investitsiya oqimlariga sezgir bo'lib qolmoqda.
%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_IKT_-_Inhibikase-Therapeutics_-_Long-Term-Debt-to-Equity "Inhibikase Therapeutics, Inc. (IKT): Uzoq muddatli qarzning kapitalga koeffitsiyenti 04.07.2022dan 01.11.2026gacha | 👁️GURU.Markets👁️")
Inhibikase Therapeutics kompaniyasining tahliliy kesimlari
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Inhibikase Therapeutics|IKT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi inhibikase.com|IKT - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Inhibikase Therapeutics, Inc.|IKT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Inhibikase Therapeutics|Tezkor likvidlik inhibikase.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Inhibikase Therapeutics Inc - IKT
Investorlar Inhibikase Therapeutics (IKT) barqarorligini uzoq muddatli qarzning kapitalga nisbati orqali baholamoqdalar, bu esa organik o'sish va kredit yuki o'rtasidagi aniq farqni ko'rish imkonini beradi. Uzoq muddatli moliyaviy qaramlik koeffitsiyenti dinamikasini tahlil qilish orqali Parkinson kasalligi terapiyasi rivojlanishi kompaniya kapitaliga tahdid soluvchi xavfli kredit instrumentlariga emas, balki qanchalik darajada ichki resurslarga tayanishini aniqlash mumkin.
Muhim raqobatchilar
Uzoq muddatli majburiyatlarning kapitalga nisbati Biogen Inc BIIB|Uzoq muddatli qarzning o'z kapitaliga nisbati NBIX (Neurocrine Biosciences Inc)|Uzoq muddatli qarzning kapitalga nisbati Regencell Corp (RGC)|Uzoq muddatli qarzning o'z kapitaliga nisbati Axsome Therapeutics AXSM|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Viking Therapeutics Inc|SUPN: Uzoq muddatli qarzning kapitalga nisbati|CPRX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi HRMY (harmonybiosciences.com)|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Praxis Corp (PRAX)|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|CBLL: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning kapitalga nisbati|ALEC - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli qarzning kapitalga nisbati Omeros Corp.|Uzoq muddatli qarzning kapitalga nisbati NGNE|Uzoq muddatli qarzning kapitalga nisbati acimmune.com (ACIU)|Uzoq muddatli qarzning o'z kapitaliga nisbati Voyager Therapeutics, Inc. VYGR|Uzoq muddatli qarzdorlikning kapitalga nisbati Neumora (NMRA)|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Tevogen Bio Inc.|ACOG (alphacognition.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati SAVA|ASRT (Assertio Therapeutics) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati COYA|VTGN (vistagen.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati OVID (Ovid Therapeutics)|acumenpharm.com (ABOS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CRVO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATHE (Alterity Therapeutics)|CLNN: Uzoq muddatli qarzning kapitalga nisbati|PepGen (PEPG) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences Inc|relmada.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANVS|GRCE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANEW Medical KLTO|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|revivapharma.com - Uzoq muddatli kreditlarning kapitalga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati Neuphoria Therapeutics Inc. (NEUP)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning kapitalga nisbati ATHA (Athira Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Addex Therapeutics Ltd. (ADXN)|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN - Uzoq muddatli qarzning kapitalga nisbati|PTIX (protagenic.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KTTA: Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning kapitalga nisbati BCLI|CARA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Chromocell Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti LBPH (Longboard Pharmaceuticals Inc)|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NKGen Biotech Corp (NKGN)|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|sagerx.com (SAGE) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Trevena Inc. - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati